New Journal from the Public Library of Science

Dear Dr. [Last Name],

I am delighted to announce that PLoS Clinical Trials, the newest open-access journal from the Public Library of Science, is due to launch in May of this year. As an open-access journal it will be freely available to all at plosclinicaltrials.org.

Call for Papers

I hope that you will support the goal of improving the reporting and availability of trial results, by submitting your work to PLoS Clinical Trials.

Benefits of publishing in PLoS Clinical Trials

  • Open access: you get the widest global audience for your work
  • You retain copyright
  • All randomized trials considered, irrespective of scope and outcome
  • Fast response to pre-submission inquiries
  • Fast, rigorous peer review by statisticians and specialist clinicians
  • Fast online publication
  • All articles listed in PubMed and cross-linked to trial registry records
  • All articles permanently archived in PubMed Central

Submissions are welcomed in neurology, rheumatology, radiology, respiratory medicine, pediatrics, and all other fields of healthcare. And remember, publication is not dependent on the results of your trial. Interim and follow-up analyses are welcomed, as well as confirmatory and "negative" results.

To find out more about submitting, go to plosclinicaltrials.org or e-mail eveitch@plos.org.

Content Alerts

Join many thousands of your colleagues and be made aware of developments at PLoS Clinical Trials by registering for Content Alerts. Simply complete the quick registration form. While PLoS Clinical Trials is multidisciplinary, articles in your specialty will be found easily through powerful, easy-to-use-linking and searching tools.

Sincerely,

Emma Veitch, PhD
Publications Manager, PLoS Clinical Trials
eveitch@plos.org


About PLoS
The Public Library of Science (PLoS) is a nonprofit organization of scientists and physicians committed to making the world's scientific and medical literature a public resource. PLoS launched PLoS Biology in 2003 (Impact Factor 13.9) and PLoS Medicine in 2004, establishing new high-quality, high-profile journals that provide scientists and physicians the opportunity to publish their most important work and make the full contents of that work freely available to anyone to read or distribute.